| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/01/2000 | US6096536 In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine |
| 08/01/2000 | US6096529 Recombinant α-2,3-sialyltransferases and their uses |
| 08/01/2000 | US6096527 Nucleic acids encoding protein tryosine kinases |
| 08/01/2000 | US6096521 Adhesin from Helicobacter pylori |
| 08/01/2000 | US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides |
| 08/01/2000 | US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096512 Cloned DNA encoding a UDP-GalNAc: Polypeptide, N-acetylgalactosaminyltransferase |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096506 Antibodies specific for growth differentiation factor-8 and methods of using same |
| 08/01/2000 | US6096505 Cotransfecting mammalian cells with separate nucleic acid elements including one with promoter, one with marker, and one with gene; culturing for gene expression; selecting cells which express the marker; then cells that express polypeptide |
| 08/01/2000 | US6096347 Healing of damaged heart tissue; grafting with submucosal tissue |
| 08/01/2000 | US6096319 Peptides with amino acid sequences |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | US6095148 Neuronal stimulation using electrically conducting polymers |
| 08/01/2000 | CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 08/01/2000 | CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 08/01/2000 | CA2047717C Monoclonal antibodies for small moieties, methods therefor |
| 08/01/2000 | CA2025350C Process for production of c-terminal .alpha.-amidated peptide |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043526A1 Mammalian serine racemase |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043524A1 Polypeptides derived from jnk3 |
| 07/27/2000 | WO2000043523A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043515A2 Methods of monitoring hiv drug resistance |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043503A1 Improved phytases |
| 07/27/2000 | WO2000043500A2 Immortalized cell lines and methods of making the same |
| 07/27/2000 | WO2000043499A2 ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043420A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043403A1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes |
| 07/27/2000 | WO2000042856A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/27/2000 | WO2000029548A3 Coupled peptides |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027998A3 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |
| 07/27/2000 | WO2000023593A3 Molecular pathogenicide mediated plant disease resistance |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 07/27/2000 | WO2000023094A3 Methods of inhibiting platelet activation and recruitment |
| 07/27/2000 | WO2000022141A3 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000009712A8 Transcription factors regulating the expression of ethylene-inducible genes |
| 07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
| 07/27/2000 | WO2000002998A9 Methods for implanting cells |
| 07/27/2000 | WO1999009149A9 Three-dimensional polymer matrices |
| 07/27/2000 | CA2391657A1 Anti-transforming growth factor beta (tgf-.beta.) treated stem cell composition and method |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360730A1 Human liver progenitors |
| 07/27/2000 | CA2360724A1 Mammalian serine racemase |
| 07/27/2000 | CA2360667A1 Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2358963A1 Cancer-associated proteins |
| 07/27/2000 | CA2358914A1 Polypeptides derived from jnk3 |
| 07/27/2000 | CA2358899A1 Polypeptide |
| 07/27/2000 | CA2358800A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | CA2356642A1 Improved phytases |
| 07/27/2000 | CA2354375A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1022335A1 High-throughput screening of gene function using libraries for functional genomics applications |
| 07/26/2000 | EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1021552A1 Transgenic lemnaceae |
| 07/26/2000 | EP1021551A1 Plant fatty acid hydroxylase genes |
| 07/26/2000 | EP1021550A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 07/26/2000 | EP1021548A1 Method for introducing and expressing rna in animal cells |
| 07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
| 07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
| 07/26/2000 | EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
| 07/26/2000 | EP1021529A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
| 07/26/2000 | EP1021527A1 Plant and viral promoters |
| 07/26/2000 | EP1021523A1 Liver regeneration using pancreas cells |
| 07/26/2000 | EP1021465A2 Gfp-annexin fusion proteins |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021197A1 Implants comprising combinations of allogeneic cells for use in cancer treatment |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/26/2000 | EP0786084A4 Method for screening compositions |
| 07/26/2000 | EP0650374B1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
| 07/26/2000 | EP0629293B1 Assay for adrenal autoantibodies |
| 07/26/2000 | CN1261404A Lentivirus-Based gene transfer vectors. |
| 07/26/2000 | CN1261402A Plant and viral promotors |
| 07/26/2000 | CN1261374A Isolated nona- and decapeptides which bind to HLA molecules,and the use thereof |
| 07/26/2000 | CN1261373A Compositions and methods for activating genes of interest |
| 07/26/2000 | CN1261372A Natural antitumor or antiviral substances and use of the same |